Supernus Pharmaceuticals Inc (SUPN)
Net profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 73,865 | 1,316 | 60,711 | 53,424 | 126,950 |
| Revenue | US$ in thousands | 661,817 | 607,521 | 673,056 | 560,079 | 500,962 |
| Net profit margin | 11.16% | 0.22% | 9.02% | 9.54% | 25.34% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $73,865K ÷ $661,817K
= 11.16%
The net profit margin of Supernus Pharmaceuticals Inc has shown fluctuations over the past five years. As of December 31, 2020, the net profit margin was 25.34%, reflecting a strong profitability ratio. However, this percentage decreased to 9.54% by the end of December 31, 2021, indicating a significant decline in profitability. The trend continued in 2022 and 2023, with net profit margins of 9.02% and 0.22%, respectively, suggesting challenges in maintaining profitability.
Fortunately, there was a notable improvement in the net profit margin for December 31, 2024, reaching 11.16%. This uptick indicates a positive shift in profitability for the company. Overall, Supernus Pharmaceuticals Inc has experienced varying levels of net profit margins in the past five years, highlighting the importance of closely monitoring and analyzing financial performance to make informed business decisions.
Peer comparison
Dec 31, 2024